Traders Sell Humana (HUM) on Strength (HUM)
Investors sold shares of Humana Inc (NYSE:HUM) on strength during trading hours on Thursday. $67.55 million flowed into the stock on the tick-up and $117.23 million flowed out of the stock on the tick-down, for a money net flow of $49.68 million out of the stock. Of all equities tracked, Humana had the 0th highest net out-flow for the day. Humana traded up $3.69 for the day and closed at $279.44
HUM has been the subject of several research analyst reports. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $273.00 price target for the company in a research note on Tuesday, October 3rd. Cowen reiterated a “buy” rating and set a $285.00 price objective on shares of Humana in a report on Wednesday, December 13th. Goldman Sachs Group initiated coverage on shares of Humana in a report on Wednesday, January 3rd. They set a “buy” rating and a $305.00 price objective for the company. Jefferies Group upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $221.00 price objective for the company in a report on Friday, January 12th. Finally, Royal Bank of Canada restated a “hold” rating and set a $245.00 price target on shares of Humana in a report on Tuesday, October 10th. Ten investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Humana presently has a consensus rating of “Buy” and an average target price of $260.10.
The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.35. The stock has a market cap of $39,920.82, a PE ratio of 21.97, a PEG ratio of 1.75 and a beta of 0.88.
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.57%. The ex-dividend date is Thursday, December 28th. Humana’s dividend payout ratio (DPR) is currently 12.59%.
Humana announced that its board has initiated a stock repurchase plan on Thursday, December 14th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the insurance provider to buy shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company’s leadership believes its stock is undervalued.
In related news, SVP Brian P. Leclaire sold 1,679 shares of the company’s stock in a transaction that occurred on Thursday, December 21st. The shares were sold at an average price of $245.97, for a total transaction of $412,983.63. Following the sale, the senior vice president now owns 9,888 shares of the company’s stock, valued at approximately $2,432,151.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Timothy S. Huval sold 1,382 shares of the company’s stock in a transaction that occurred on Tuesday, December 19th. The stock was sold at an average price of $246.04, for a total transaction of $340,027.28. Following the sale, the vice president now directly owns 11,557 shares in the company, valued at approximately $2,843,484.28. The disclosure for this sale can be found here. Insiders have sold a total of 10,115 shares of company stock worth $2,501,627 in the last ninety days. 0.80% of the stock is currently owned by insiders.
Several large investors have recently modified their holdings of the company. WFG Advisors LP increased its holdings in shares of Humana by 4.5% in the 2nd quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock worth $113,000 after buying an additional 20 shares during the last quarter. Nordea Investment Management AB boosted its stake in shares of Humana by 1.0% in the 2nd quarter. Nordea Investment Management AB now owns 7,338 shares of the insurance provider’s stock valued at $1,766,000 after purchasing an additional 74 shares in the last quarter. Scotia Capital Inc. boosted its stake in shares of Humana by 4.8% in the 2nd quarter. Scotia Capital Inc. now owns 2,200 shares of the insurance provider’s stock valued at $529,000 after purchasing an additional 100 shares in the last quarter. PNC Financial Services Group Inc. boosted its stake in shares of Humana by 0.5% in the 2nd quarter. PNC Financial Services Group Inc. now owns 40,084 shares of the insurance provider’s stock valued at $9,645,000 after purchasing an additional 199 shares in the last quarter. Finally, Advantus Capital Management Inc boosted its stake in shares of Humana by 1.4% in the 3rd quarter. Advantus Capital Management Inc now owns 14,798 shares of the insurance provider’s stock valued at $3,605,000 after purchasing an additional 203 shares in the last quarter. 94.01% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: “Traders Sell Humana (HUM) on Strength (HUM)” was originally reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another site, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.watchlistnews.com/traders-sell-humana-hum-on-strength-hum/1815635.html.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.